Cited by 778Phagocytosis and Immune RegulationCell death mechanisms and regulationAutophagy in Disease and Therapy

The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.

Calreticulin Is the Dominant Pro-Phagocytic Signal on Multiple Human Cancers and Is Counterbalanced by CD47

Open access

Chao, Mark P., Jaiswal, Siddhartha, Weissman-Tsukamoto, Rachel, Alizadeh, Ash A., Gentles, Andrew J., Volkmer, Jens, Weiskopf, Kipp, Willingham, Stephen B., Raveh, Tal, Park, Christopher Y., Majeti, Ravindra, Weissman, Irving L.·2010·Science Translational Medicine

DOI 10.1126/scitranslmed.3001375PMC PMC4126904

Open this paper in CoChat — free account

Abstract

Calreticulin-induced phagocytosis of cancer cells can be counterbalanced by CD47 expression.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1126/scitranslmed.3001375

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The hallmarks of cancer
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
Self-citation
Identification of human brain tumour initiating cells
Singh, S. K., Hawkins, C. E., Clarke, I. D., Squire, J. A., Bayani, J., Hide, T., Henkelman, R. M., Cusimano, M. D., & Dirks, P. B. (2004) · Nature · doi:10.1038/nature03128 · Cited by 7,564
A cell initiating human acute myeloid leukaemia after transplantation into SCID mice
Lapidot, T., Sirard, C., Vormoor, J., Murdoch, B., Hoang, T., Caceres-Cortes, J., Minden, M., Paterson, B., Caligiuri, M. A., & Dick, J. E. (1994) · Nature · doi:10.1038/367645a0 · Cited by 4,783
Calreticulin exposure dictates the immunogenicity of cancer cell death
Obeid, M., Tesniere, A., Ghiringhelli, F., Fimia, G. M., Apetoh, L., Perfettini, J.-L., Castedo, M., Mignot, G., Panaretakis, T., Casares, N., et al. (2007) · Nature Medicine · doi:10.1038/nm1523 · Cited by 3,216
Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data
Dai, M. (2005) · Nucleic Acids Research · doi:10.1093/nar/gni179 · Cited by 1,807
CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells
Majeti, R., Chao, M. P., Alizadeh, A. A., Pang, W. W., Jaiswal, S., Gibbs, K. D., van Rooijen, N., & Weissman, I. L. (2009) · Cell · doi:10.1016/j.cell.2009.05.045 · Cited by 1,752
Self-citation
CD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid Phagocytosis
Jaiswal, S., Jamieson, C. H. M., Pang, W. W., Park, C. Y., Chao, M. P., Majeti, R., Traver, D. J., van Rooijen, N., & Weissman, I. L. (2009) · Cell · doi:10.1016/j.cell.2009.05.046 · Cited by 1,578
Self-citation
A blast from the past: clearance of apoptotic cells regulates immune responses
Savill, J., Dransfield, I., Gregory, C. D., & Haslett, C. (2002) · Nature reviews. Immunology · doi:10.1038/nri957 · Cited by 1,574
Immune surveillance of tumors
Swann, J. B., & Smyth, M. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31405 · Cited by 1,518
Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML
Jamieson, C. H. M., Ailles, L. E., Dylla, S. J., Muijtjens, M., Jones, C., Zehnder, J. L., Gotlib, J., Li, K., Manz, M. G., Keating, A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040258 · Cited by 1,485 · cited 12×
“For analysis of normal peripheral blood cells, normal bonemarrow cells, AML, CML, ALL, bladder cancer, ovarian cancer, and brain cancer, the following antibodieswere used: CD34,CD38, CD90,CD45, CD31,CD3, CD4, CD7, CD11b, CD14, CD19, CD20, CD56, andGlycophorinA (Invitrogen and BD Biosciences).”
BackgroundInfluentialSelf-citation
Cell-Surface Calreticulin Initiates Clearance of Viable or Apoptotic Cells through trans-Activation of LRP on the Phagocyte
Gardai, S. J., McPhillips, K. A., Frasch, S. C., Janssen, W. J., Starefeldt, A., Murphy-Ullrich, J. E., Bratton, D. L., Oldenborg, P.-A., Michalak, M., & Henson, P. M. (2005) · Cell · doi:10.1016/j.cell.2005.08.032 · Cited by 1,473
Cancer despite immunosurveillance: immunoselection and immunosubversion
Zitvogel, L., Tesniere, A., & Kroemer, G. (2006) · Nature reviews. Immunology · doi:10.1038/nri1936 · Cited by 1,324
Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma
Chao, M. P., Alizadeh, A. A., Tang, C. Z., Myklebust, J. H., Varghese, B., Gill, S. I., Jan, M., Cha, A. C., Chan, C. K. F., Tan, B. T., et al. (2010) · Cell · doi:10.1016/j.cell.2010.07.044 · Cited by 1,124
Self-citation
The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma
Rosenwald, A., Wright, G. W., Wiestner, A. U., Chan, W. C., Connors, J. M., Campo, E., Gascoyne, R. D., Grogan, T. M., Müller-Hermelink, H. K., Smeland, E. B., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00028-x · Cited by 913
Surface exposure of phosphatidylserine in pathological cells
Zwaal, R. F. A., Comfurius, P., & Bevers, E. M. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-4527-3 · Cited by 753
Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells
Chan, K. S., Espinosa, Í., Chao, M. P., Wong, D. J., Ailles, L., Diehn, M., Gill, H. S., Presti, J. C., Chang, H. Y., van de Rijn, M., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906549106 · Cited by 669
Self-citation
Elevated expression of phosphatidylserine in the outer membrane leaflet of human tumor cells and recognition by activated human blood monocytes.
Utsugi, T., Schroit, A. J., Connor, J., Bucana, C. D., & Fidler, I. J. (1991) · PubMed · Cited by 594
Calreticulin exposure is required for the immunogenicity of γ-irradiation and UVC light-induced apoptosis
Obeid, M., Panaretakis, T., Joza, N., Tufi, R., Tesniere, A., van Endert, P., Zitvogel, L., & Kroemer, G. (2007) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402201 · Cited by 474
The SIRP family of receptors and immune regulation
Barclay, A. N., & Brown, M. H. (2006) · Nature reviews. Immunology · doi:10.1038/nri1859 · Cited by 427
Annexin 1: the new face of an old molecule
Lim, L. H. K., & Pervaiz, S. (2007) · The FASEB Journal · doi:10.1096/fj.06-7464rev · Cited by 399
Predictive value of progression-related gene classifier in primary non-muscle invasive bladder cancer
Kim, W., Kim, E., Kim, S., Kim, Y., Ha, Y., Jeong, P., Kim, M.-J., Yun, S. J., Lee, K. M., Moon, S., et al. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-3 · Cited by 396
Calreticulin is essential for integrin-mediated calcium signalling and cell adhesion
Coppolino, M. G., Woodside, M. J., Demaurex, N., Grinstein, S., St‐Arnaud, R., & Dedhar, S. (1997) · Nature · doi:10.1038/386843a0 · Cited by 392
Integrin-associated Protein Is a Ligand for the P84 Neural Adhesion Molecule
Jiang, P., Lagenaur, C. F., & Narayanan, V. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.2.559 · Cited by 353
The co-translocation of ERp57 and calreticulin determines the immunogenicity of cell death
Panaretakis, T., Joza, N., Modjtahedi, N., Tesniere, A., Vitale, I., Durchschlag, M., Fimia, G. M., Kepp, O., Piacentini, M., Froehlich, K.-U., et al. (2008) · Cell Death & Differentiation · doi:10.1038/cdd.2008.67 · Cited by 344
Lack of Expression of Thy-1 (CD90) on Acute Myeloid Leukemia Cells With Long-Term Proliferative Ability In Vitro and In Vivo
Blair, A., Hogge, D. E., Ailles, L. E., Lansdorp, P. M., & Sutherland, H. J. (1997) · Blood · doi:10.1182/blood.v89.9.3104 · Cited by 335
Vasostatin, a Calreticulin Fragment, Inhibits Angiogenesis and Suppresses Tumor Growth
Pike, S. E., Yao, L., Jones, K. D., Cherney, B., Appella, E., Sakaguchi, K., Nakhasi, H. L., Teruya‐Feldstein, J., Wirth, P. J., Gupta, G., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2349 · Cited by 310
LDL receptor‐related protein: a multiligand receptor for lipoprotein and proteinase catabolism
Strickland, D. K., Kounnas, M. Z., & Argraves, W. S. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.10.7615159 · Cited by 268
Macrophages as mediators of tumor immunosurveillance
Jaiswal, S., Chao, M. P., Majeti, R., & Weissman, I. L. (2010) · Trends in Immunology · doi:10.1016/j.it.2010.04.001 · Cited by 249
Self-citation
In vivo expression of alternatively spliced forms of integrin-associated protein (cd47)
Reinhold, M. I., Lindberg, F. P., Plas, D. R., Reynolds, S., Peters, M. G., & Brown, E. J. (1995) · Journal of Cell Science · doi:10.1242/jcs.108.11.3419 · Cited by 233
Emmprin and Survivin Predict Response and Survival following Cisplatin-Containing Chemotherapy in Patients with Advanced Bladder Cancer
Als, A. B., Dyrskjøt, L., von der Maase, H., Koed, K., Mansilla, F., Toldbod, H., Jensen, J. L., Ulhøi, B. P., Sengeløv, L., Jensen, K. M., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0109 · Cited by 203
Differentiation-dependent expression of phosphatidylserine in mammalian plasma membranes: quantitative assessment of outer-leaflet lipid by prothrombinase complex formation.
Connor, J., BUCANA, C. D., Fidler, I. J., & Schroit, A. J. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.9.3184 · Cited by 186
Calreticulin and Calreticulin Fragments Are Endothelial Cell Inhibitors That Suppress Tumor Growth
Pike, S. E., Yao, L., Setsuda, J., Jones, K. D., Cherney, B., Appella, E., Sakaguchi, K., Nakhasi, H. L., Atreya, C. D., Teruya‐Feldstein, J., et al. (1999) · Blood · doi:10.1182/blood.v94.7.2461.419a26_2461_2468 · Cited by 177
Radioprotection in Normal Tissue and Delayed Tumor Growth by Blockade of CD47 Signaling
Maxhimer, J. B., Soto‐Pantoja, D. R., Ridnour, L. A., Shih, H. B., DeGraff, W., Tsokos, M., Wink, D. A., Isenberg, J. S., & Roberts, D. D. (2009) · Science Translational Medicine · doi:10.1126/scitranslmed.3000139 · Cited by 176
Thrombospondin signaling through the calreticulin/LDL receptor-related protein co-complex stimulates random and directed cell migration
Orr, A. W., Elzie, C. A., Kucik, D. F., & Murphy-Ullrich, J. E. (2003) · Journal of Cell Science · doi:10.1242/jcs.00600 · Cited by 174
Low density lipoprotein receptor–related protein is a calreticulin coreceptor that signals focal adhesion disassembly
Orr, A. W., Pedraza, C. E., Pallero, M. A., Elzie, C. A., Goicoechea, S. M., Strickland, D. K., & Murphy-Ullrich, J. E. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200302069 · Cited by 168
Self inhibition of phagocytosis: The affinity of ‘marker of self’ CD47 for SIRPα dictates potency of inhibition but only at low expression levels
Tsai, R. K., Rodriguez, P. L., & Discher, D. E. (2010) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2010.02.016 · Cited by 143
Calreticulin Is Expressed on the Cell Surface of Activated Human Peripheral Blood T Lymphocytes in Association with Major Histocompatibility Complex Class I Molecules
Arosa, F. A., de Jesus, O., Porto, G., Carmo, A. M., & de Sousa, M. A. B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.24.16917 · Cited by 135
Identification of Calreticulin as a Prognosis Marker and Angiogenic Regulator in Human Gastric Cancer
Chen, C., Chang, C.-C., Su, T., Hsu, W., Jeng, Y., Ho, M., Hsieh, F., Lee, P., Kuo, M., Lee, H., et al. (2008) · Annals of Surgical Oncology · doi:10.1245/s10434-008-0243-1 · Cited by 130
The roles of receptor-associated protein (RAP) as a molecular chaperone for members of the LDL receptor family
Bu, G. (2001) · International review of cytology · doi:10.1016/s0074-7696(01)09011-8 · Cited by 122
Dissection of receptor folding and ligand-binding property with functional minireceptors of LDL receptor-related protein
Obermoeller-McCormick, L. M., Li, Y., Osaka, H., FitzGerald, D. J., Schwartz, A. L., & Bu, G. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.5.899 · Cited by 110
PAI-1 inhibits neutrophil efferocytosis
Park, Y.-J., Liu, G., Lorne, E., Zhao, X., Wang, J., Tsuruta, Y., Zmijewski, J. W., & Abraham, E. H. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801394105 · Cited by 110
Accurate Outcome Prediction in Neuroblastoma across Independent Data Sets Using a Multigene Signature
Preter, K. D., Vermeulen, J., Brors, B., Delattre, O., Eggert, A., Fischer, M., Janoueix‐Lerosey, I., Lavarino, C. E., Maris, J. M., Mora, J., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2607 · Cited by 98
ERP57 Membrane Translocation Dictates the Immunogenicity of Tumor Cell Death by Controlling the Membrane Translocation of Calreticulin
Obéid, M. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.4.2533 · Cited by 98
Calreticulin‐dependent recycling in the early secretory pathway mediates optimal peptide loading of MHC class I molecules
Howe, C. M., Garstka, M. A., Al-Balushi, M. S., Ghanem, E., Antoniou, A. N., Fritzsche, S., Jankevicius, G., Kontouli, N., Schneeweiß, C., Williams, A. P., et al. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.296 · Cited by 97
Enhanced exposure of phosphatidylserine in human gastric carcinoma cells overexpressing the half-size ABC transporter BCRP (ABCG2)
Woehlecke, H., Pohl, A., Alder‐Baerens, N., Lage, H., & Herrmann, A. (2003) · Biochemical Journal · doi:10.1042/bj20030886 · Cited by 94
Calreticulin expression in neuroblastoma—a novel independent prognostic factor
Hsu, W., Hsieh, F. ‐., Jeng, Y., Kuo, M., Chen, C., Lai, D., Hsieh, L., Wang, B. T., Tsao, P., Lee, H., et al. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi062 · Cited by 93
Calreticulin Is at the Surface of Circulating Neutrophils and Uses CD59 as an Adaptor Molecule
Ghiran, I. C., Klickstein, L. B., & Nicholson-Weller, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302306200 · Cited by 92
From cancer immunosurveillance to cancer immunotherapy
Stagg, J., Johnstone, R. W., & Smyth, M. J. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00566.x · Cited by 91
Binding of annexin V to a human ovarian carcinoma cell line (OC-2008). Contrasting effects on cell surface factor VIIa/tissue factor activity and prothrombinase activity
Rao, L. V. M., Tait, J. F., & Hoang, A. D. (1992) · Thrombosis Research · doi:10.1016/0049-3848(92)90013-z · Cited by 84
Comparison of performance of one-color and two-color gene-expression analyses in predicting clinical endpoints of neuroblastoma patients
Oberthuer, A., Juraeva, D., Li, L., Kahlert, Y., Westermann, F., Eils, R., Berthold, F., Shi, L. M., Wolfinger, R. D., Fischer, M., et al. (2010) · The Pharmacogenomics Journal · doi:10.1038/tpj.2010.53 · Cited by 67
Explorative data analysis of MCL reveals gene expression networks implicated in survival and prognosis supported by explorative CGH analysis
Blenk, S., Engelmann, J. C., Pinkert, S., Weniger, M., Schultz, J., Rosenwald, A., Müller‐Hermelink, H. K., Müller, T., & Dandekar, T. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-106 · Cited by 48
Decreased CD47 expression during spontaneous apoptosis targets neutrophils for phagocytosis by monocyte-derived macrophages
Lawrence, D. W., King, S. B., Frazier, W. A., & Koenig, J. M. (2009) · Early Human Development · doi:10.1016/j.earlhumdev.2009.09.005 · Cited by 31
Gene Transfer of Vasostatin, a Calreticulin Fragment, into Neuroendocrine Tumor Cells Results in Enhanced Malignant Behavior
Liu, M., Imam, H., Öberg, K., & Zhou, Y. (2005) · Neuroendocrinology · doi:10.1159/000089749 · Cited by 15
Untitled work
(2003) · PubMed

Sorted by citations

Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018.
Galluzzi, L., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Agostinis, P., Alnemri, E. S., Altucci, L., Amelio, I., Andrews, D. W., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0012-4 · Cited by 6,680
Immunogenic Cell Death in Cancer Therapy
Kroemer, G., Galluzzi, L., Kepp, O., & Zitvogel, L. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-100008 · Cited by 3,303
Somatic CALR Mutations in Myeloproliferative Neoplasms with Nonmutated JAK2
Nangalia, J., Massie, C. E., Baxter, E. J., Nice, F. L., Gundem, G., Wedge, D. C., Avezov, E., Li, J., Kollmann, K., Kent, D. G., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1312542 · Cited by 1,756
The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
Willingham, S. B., Volkmer, J.-P., Gentles, A. J., Sahoo, D., Dalerba, P. D., Mitra, S. S., Wang, J., Contreras-Trujillo, H., Martin, R. K., Cohen, J. D., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121623109 · Cited by 1,706
Self-citation
Autophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice
Michaud, M., Martins, I., Sukkurwala, A. Q., Adjemian, S., Ma, Y., Pellegatti, P., Shen, S., Kepp, O., Scoazec, M., Mignot, G., et al. (2011) · Science · doi:10.1126/science.1208347 · Cited by 1,377

See all 778

Authors: Chao, M. P., Jaiswal, S., Weissman-Tsukamoto, R., Alizadeh, A. A., Gentles, A. J., Volkmer, J., Weiskopf, K., Willingham, S. B., Raveh, T., Park, C. Y., Majeti, R., & Weissman, I. L.
Affiliations: Institute for Stem Cell Biology and Regenerative Medicine (US)
Massachusetts General Hospital (US)
Stanford Medicine (US)
Stanford University (US)
Memorial Sloan Kettering Cancer Center (US)
Corresponding author: Chao, Mark P.
Majeti, Ravindra
Weissman, Irving L.
ORCID: Chao, Mark P.
Jaiswal, Siddhartha
Alizadeh, Ash A.
Gentles, Andrew J.
Weiskopf, Kipp
Raveh, Tal
Park, Christopher Y.
Majeti, Ravindra
Weissman, Irving L.
Venue: Science Translational Medicine
Publisher: American Association for the Advancement of Science (AAAS)
Published: 2010-12-22
Volume: 2
Issue: 63
Pages: 63ra94-63ra94
ISSN: 1946-6234 (ISSN-L)
1946-6242
DOI: 10.1126/scitranslmed.3001375
PMC: PMC4126904
OpenAlex: W2142541925
Cited by: 776
References: 55
Citations by year: 2026: 35 · 2025: 51 · 2024: 62 · 2023: 81 · 2022: 76 · 2021: 72 · 2020: 62 · 2019: 54 · 2018: 40 · 2017: 48 · 2016: 36 · 2015: 49 · 2014: 31 · 2013: 28 · 2012: 36
FWCI: 10.73
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Science Translational Medicine (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: Howard Hughes Medical Institute
National Cancer Institute (U54CA149145, CA09302, P01CA139490, R01CA086017, T32CA009302)
Topics: Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
Keywords: calreticulin, CD47, anti-CD47 antibody, low density lipoprotein receptor-related protein, tumor immune evasion, prognostic factors, acute myeloid leukemia, non-Hodgkin lymphoma, bladder cancer, neuroblastoma, innate immunity
MeSH terms: Animals, Urinary Bladder Neoplasms, Cell Line, Flow Cytometry, Humans, Lymphoma, Non-Hodgkin, Phagocytosis, Leukemia, Myeloid, Acute, Calreticulin, Cell Line, Tumor, Mice, CD47 Antigen, In Vitro Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Calreticulin Is the Dominant Pro-Phagocytic Signal on Multiple Human Cancers and Is Counterbalanced by CD47

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks